Pioglitazone Reverses Insulin Resistance in Type 2 Diabetes

Pioglitazone Reverses Insulin Resistance in Type 2 Diabetes – MM1311

Insulin resistance is a common feature and contains several cardiovascular risk factors: dyslipidaemia, hypertension, glucose intolerance, hypercoagulability,
obesity, hyperinsulinaemia and low-grade inflammation.

Modern Medicine – November/December 2013

Verified by ExactMetrics